NPR's Richard Knox reports that the debate over AIDS drugs to the developing world is expanding to Latin America. The nations of Central and South America are actually better poised to take advantage of lower prices, because health infrastructures are more advanced. But pharmaceutical giants are already aiming to stop further erosion of their prices. Last week in Quebec City, new anti-generic rules were proposed that would protect patents on brand name drugs in Central and South America.
Copyright 2001 NPR
